Creo Medical Limited

LSE:CREO.L

Market Cap

USD 72.06 M

Share Price

USD 0.17

Avg Daily Volume

1,781,555

Change (1 day)

0.91%

Change (1 year)

-60.09%

Change (YTD)

-31.17%

Creo Medical Limited EBIT Margin for the year ending December 31, 2024: -715.00%

Creo Medical Limited EBIT Margin is -715.00% for the year ending December 31, 2024, a 813.78% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Creo Medical Limited EBIT Margin for the year ending December 31, 2023 was -78.25%, a -30.82% change year over year.
  • Creo Medical Limited EBIT Margin for the year ending December 31, 2022 was -113.10%, a -5.46% change year over year.
  • Creo Medical Limited EBIT Margin for the year ending December 31, 2021 was -119.64%, a -51.72% change year over year.
  • Creo Medical Limited EBIT Margin for the year ending December 31, 2020 was -247.80%, a -99.82% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin